Fund Holdings — Wildcat Capital Management, LLC

Total Portfolio Value
$252.71M
Total Bought
$1.48M
Total Sold
$6.04M
Net Transaction
-$4.57M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
FRONTIER GROUP HLDGS INC(ULCC)28,061,35128,061,3510150,128199,51678.95%+49,388
RLX TECHNOLOGY INC(RLX)18,046,19518,046,195032,66438,98015.42%+6,316
GITLAB INC(GTLB)011,399+11,39906420.25%+642
PROCORE TECHNOLOGIES INC(PCOR)08,095+8,09506070.24%+607
SILEXION THERAPEUTICS CORP0113,428+113,42802280.09%+228
KRONOS BIO INC1,297,9591,297,95901,2981,2330.49%-65
SILEXION THERAPEUTICS CORP1,020,8520-1,020,8525360—-536
UROGEN PHARMA LTD(URGN)495,606495,60606,2945,2782.09%-1,016
ALLOGENE THERAPEUTICS INC2,920,7872,920,78708,1786,2212.46%-1,957
SKILLZ INC(FIRY)979,8480-979,8485,5070—-5,507
Page 1 of 1
Wildcat Capital Management, LLC — 13F Holdings — Q4 2024 | TickerTrail